Form 4: Centene Director Boosts Stake with 943 Share Acquisition

Centene Corp. Director Theodore R. Samuels II acquired 943 shares of common stock on March 31, 2026, increasing his direct beneficial ownership.

Summary

• Theodore R. Samuels II, a Director of Centene Corp. (CNC), acquired 943 shares of common stock.
• The transaction occurred on March 31, 2026, at a price of $0 per share, indicating a grant or award.
• Following this acquisition, Mr. Samuels directly beneficially owns 20,755.979 shares of Centene common stock.
• His total beneficial ownership also includes 32,000 shares held indirectly through a revocable family trust, for which he serves as a co-trustee.
• Direct ownership includes 3,579 shares of restricted stock units subject to vesting requirements.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as a director increasing their stake, even through a grant, demonstrates continued confidence in the company's future prospects and aligns their interests with shareholders.

Positives

• Director Theodore R. Samuels II increased his direct beneficial ownership by acquiring 943 shares, signaling continued confidence in Centene Corp.
• The acquisition, likely a compensation grant, aligns the director's interests with those of shareholders.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic outlook.

Industry Context

StockSavvy.ai notes that insider acquisitions, even those resulting from compensation grants, are generally viewed as a positive signal, indicating management's continued alignment with shareholder interests. Such transactions are a routine part of executive and director compensation in publicly traded companies within the healthcare sector.

Comparison to Industry Standards

• Insider equity grants are a standard component of executive and director compensation across various industries, including healthcare, aligning leadership incentives with company performance.
• The acquisition of 943 shares by a director of a large-cap company like Centene is a relatively modest amount compared to the total outstanding shares, typical for routine compensation rather than a significant market purchase.
• Comparable companies in the managed care sector, such as UnitedHealth Group (UNH) or Elevance Health (ELV), also frequently report similar insider grants as part of their compensation structures for directors and executives.

Related Party Transactions

• Theodore R. Samuels II indirectly beneficially owns 32,000 shares through a revocable family trust, of which he serves as a co-trustee, representing a related party holding.

Stakeholder Impact

• Shareholders may view the director's increased ownership as a positive indicator of management confidence and alignment.
• Employees and other stakeholders might interpret this as a sign of stability and commitment from the company's leadership.

Key Dates

Keywords

Centene, CNC, Insider Transaction, Form 4, Director Stock Acquisition, Theodore R. Samuels II, Restricted Stock Units, Equity Compensation